A comparison of Symbicort single inhaler and conventional best practice for the treatment of persistent asthma in adolescents and adults - a 26-week, randomised, open, parallel group multicentre study.
Phase of Trial: Phase III
Latest Information Update: 21 Jan 2011
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms SYMPHONIE
- Sponsors AstraZeneca
- 05 Dec 2006 Status change
- 29 Mar 2006 New trial record.